Benzinga - by Avi Kapoor, Benzinga Staff Writer.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy .
Below are the ratings of the most accurate analysts for three high-yielding stocks in the financial sector.
New York Community Bancorp, Inc. (NYSE: NYCB)
- Dividend Yield: 6.15%
- Keefe, Bruyette & Woods analyst Christopher Mcgratty maintained a Market Perform rating and cut the price target from $7.5 to $3.75 on March 11, 2024. This analyst has an accuracy rate of 66%.
- Citigroup analyst Keith Horowitz maintained a Neutral rating and lowered the price target from $5 to $3.5 on March 7, 2024. This analyst has an accuracy rate of 78%.
- Recent News: On March 6, New York Community Bancorp announced an equity investment of over $1 billion by investors including Liberty Strategic Capital, Hudson Bay and Reverence Capital.
- Dividend Yield: 6.26%
- Truist Securities analyst Mark Hughes maintained a Hold rating and raised the price target from $43 to $45 on Feb. 26, 2024. This analyst has an accuracy rate of 84%.
- B. Riley Securities analyst Bryce Rowe downgraded the stock from Buy to Neutral with a price target of $47 on Jan. 8, 2024. This analyst has an accuracy rate of 61%.
- Recent News: On Feb. 22, Main Street Capital posted upbeat quarterly earnings.
- Dividend Yield: 6.69%
- BMO Capital analyst Rufus Hone maintained a Market Perform rating and raised the price target from $12 to $13 on Feb. 7, 2024. This analyst has an accuracy rate of 76%.
- UBS analyst Timothy Chiodo assumed a Neutral rating with a price target of $14 on Oct. 20, 2023. This analyst has an accuracy rate of 62%.
- Recent News: On March 5, Visa disclosed a 7-year agreement with Western Union.
Read More: Cramer Says This Healthcare Stock Can Go Higher, Calls Manhattan Associates 'A Winner'
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.